Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Restrict the search for sulfisoxazole acetyl to a specific field?

Exact Matches

1
Display Name

1
Standardized Name

1
Any Name

Approximate Matches

1
Display Name

1
Standardized Name

1
Any Name

1
Reference Text / Citation

Approximate Matches

2457
Standardized Name

2457
Any Name

741
Display Name

651
Note

269
Related Substance Name

140
Reference Text / Citation

86
Protein Structural Modification Substance Name

74
root_modifications_structuralModifications_molecularFragment_refPname

40
Monomer Substance Name

33
Code Literal

27
Reference URL

16
Code URL

15
WIKIPEDIA

13
Code Comments

13
JECFA EVALUATION

8
Relationship Comments

5
Mixture Component Name

3
CDC

1
LACTMED

1
MANUFACTURER PRODUCT INFORMATION

Showing 671 - 680 of 2738 results

First page
Previous page
Next page
Next page

Pentarane A

UMG87A58PN

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

2-(2-FLUOROPHENYL)-3-OXOBUTYRONITRILE

BCG8MG34XH

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (RACEMIC)

DEC-TA 870

V87I081SWP

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

GANIRELIX 1-4 PEPTIDE

JI8UK4P16N

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

selenosugar B

ZCQ8TN7ZMH

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

GSK-2606414

DPP2K6EFW8

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Eukaryotic translation initiation factor 2-alpha kinase 3

Conditions:

Neurodegenerative diseases

GSK2606414 is an orally bioavailable, potent, selective inhibitor of PERK. The drug may serve as a potential treatment for cancer and neurodegenerative diseases associated with the accumulation and aggregation of misfolded disease-specific proteins in the brain. GSK2606414 demonstrated good results on a mouse model of prion disease.

DU-41165

5M4PL394K5

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

POTASSIUM HYDROGEN N-ACETYL-L-ASPARTATE

XU67SI76JA

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

5-(Acetyl(2,3-dihydroxypropyl)amino)-N-(2-(acetyloxy)-3-hydroxypropyl)-N'-(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide

O47J07AS6X

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (MIXED)

ACETYL SIMVASTATIN

171OXS3HEK

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

Structure of Pentarane A

ABSOLUTE

Structure of 2-(2-FLUOROPHENYL)-3-OXOBUTYRONITRILE

RACEMIC

2-(2-FLUOROPHENYL)-3-OXOBUTYRONITRILE

Structure of DEC-TA 870

ABSOLUTE

Structure of GANIRELIX 1-4 PEPTIDE

ABSOLUTE

GANIRELIX 1-4 PEPTIDE

Structure of selenosugar B

ABSOLUTE

Structure of GSK-2606414

ACHIRAL

Structure of DU-41165

ABSOLUTE

Structure of POTASSIUM HYDROGEN N-ACETYL-L-ASPARTATE

ABSOLUTE

POTASSIUM HYDROGEN N-ACETYL-L-ASPARTATE

Structure of 5-(Acetyl(2,3-dihydroxypropyl)amino)-N-(2-(acetyloxy)-3-hydroxypropyl)-N'-(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide

MIXED

5-(Acetyl(2,3-dihydroxypropyl)amino)-N-(2-(acetyloxy)-3-hydroxypropyl)-N'-(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide

Structure of ACETYL SIMVASTATIN

ABSOLUTE

ACETYL SIMVASTATIN

Showing 671 - 680 of 2738 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1